• Atopica for Cats

Atopica for Cats

Atopica for cats (cyclosporine oral solution, USP) is indicated for the control of feline allergic dermatitis as manifested by excoriations (including face and neck), miliary dermatitis, eosinophilic plaques, and self-induced alopecia in cats at least 6 months of age and 1.4kg body weight.

Proven effective

  • Atopica is proven to significantly reduce skin lesions and relieve pruritus in cats1,2,3

What to consider when prescribing Atopica for Cats

Cats that are prescribed Atopica for Cats should:
  • Be FeLV/FIV negative
  • Have no neoplasia or history of malignancy – while cyclosporine does not induce tumors it does inhibit T-lymphocytes and therefore may increase the growth rate of pre-existing neoplastic cell populations
  • Have toxoplasmosis risk assessed

Cats with no previous exposure to Toxoplasma gondii may be at risk of developing clinical toxoplasmosis if they become infected while under treatment with Atopica for Cats. In cases of clinical toxoplasmosis or other serious systemic illness, stop treatment with cyclosporine and initiate appropriate therapy.

Cats can be tested for previous toxoplasmosis exposure by measurement of IgG and IgM. However, interpretation of titers can be complicated as there are no agreed titer levels above which previous exposure and immunity can be confirmed; veterinarians should consult with their laboratory.

Pet owners should be advised to minimize potential exposure of seronegative cats to Toxoplasma. Explain that they should:
  • Avoid feeding their cat raw meat
  • Discourage hunting (bells on collar)
  • Prevent scavenging behavior where possible
  • Keep cats indoors (some specialists advise there may be a stress component to allergic skin disease which could be exacerbated)

Treatment with Atopica for Cats has been shown not to increase Toxoplasma oocyst shedding, a potential source of zoonotic disease.


As with Atopica for Dogs, there is no need to monitor cyclosporine blood levels during administration of Atopica for Cats as no correlation has been shown between blood levels and efficacy or safety.

View full product label for Atopica

References: 1. Steffan J et al. Vet Dermatol (2013);24:315-e70. 2. King S et al. Vet Dermatol (2012);23:440-e84. 3. Roberts ES et al. J Feline Med Surg (2016);1-9.